Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial.
前列腺癌診斷中雙參數與多參數MRI之比較:PRIME診斷性臨床試驗
JAMA 2025-09-13
Overall Survival with Amivantamab-Lazertinib in <i>EGFR</i>-Mutated Advanced NSCLC.
Amivantamab-Lazertinib 用於 EGFR 突變型晚期非小細胞肺癌(NSCLC)的總體存活率
N Engl J Med 2025-09-09
Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials.
加強型血壓控制與標準血壓控制在心血管與腎臟結局上的效益與風險權衡:隨機對照試驗個別參與者資料分析
Lancet 2025-09-08